Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03481205 · ClinicalTrials.gov registry record · NA

Ischemic Conditioning During Air tRansport Save penUmbral Tissue

A NA study of Acute Stroke, sponsored by Enrique Leira.

Recruiting
Registry status
NA
Development phase
10
Enrollment target
1
Study location

NCT03481205: Recruiting NA study of Acute Stroke, sponsored by Enrique Leira.

NCT03481205 is a NA study of Acute Stroke that is actively recruiting participants, run by Enrique Leira. The registered enrollment target is 10 participants, below the 6,125-participant average among 10 other Acute Stroke trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03481205, a NA study of Acute Stroke, is actively recruiting participants, sponsored by Enrique Leira.

RECRUITING
Registry status
NA
Development phase
10 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to demonstrate the feasibility of performing remote limb ischemic conditioning (RLIC) using the Doctormate device, a special blood pressure device used to perform RLIC, on patients with acute ischemic stroke due to large vessel occlusion being transported to a thrombectomy capable center by the helicopter.

Primary Outcome

Feasibility will be assessed based on the number of cycles performed during transportation by air as follows: For flight time of duration of ≥ 60 minutes, ≥ 60% of subjects should receive 4 cycles of RLIC. For flight time of duration of 30-60 minutes, ≥ 60% of subjects should receive at least 3 cycles of RLIC. For flight duration of \< 30 minutes, ≥60% of subjects should receive at least 2 cycle of RLIC.

Conditions Studied

Interventions

  • DEVICE Ischemic conditioning device

Study Locations (1)

Iowa

  • University of Iowa - Iowa City

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2020-06-01
Est. Completion 2026-12-31
Phase NA
Enrique Leira

1 total trials

What NCT03481205 shows while recruiting

NCT03481205 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 6,125-participant average among 10 other Acute Stroke trials with a reported enrollment target (100% lower).

The record links to 1 condition, with Acute Stroke appearing as the primary indexed condition, and to 1 intervention - of which Ischemic conditioning device is the first listed.

NCT03481205 reports a single indexed study location in Iowa.

Frequently Asked Questions

What is clinical trial NCT03481205 about?

NCT03481205 is a clinical study titled "Ischemic Conditioning During Air tRansport Save penUmbral Tissue". The purpose of this study is to demonstrate the feasibility of performing remote limb ischemic conditioning (RLIC) using the Doctormate device, a special blood pressure device used to perform RLIC, on patients with acute ischemic stroke due to large vessel occlusion being transported to a thrombecto...

What is the current status of trial NCT03481205?

This trial is currently recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2020-06-01. Estimated completion is 2026-12-31.

What conditions does trial NCT03481205 study?

This clinical trial studies the following conditions: Acute Stroke.

What interventions are being tested in trial NCT03481205?

The interventions under investigation include: Ischemic conditioning device (DEVICE).

Who is sponsoring clinical trial NCT03481205?

This trial is sponsored by Enrique Leira, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03481205 being conducted?

This trial has 1 study location across Iowa. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Acute Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03481205's enrollment target sits among peer trials

10 11th of 10 the lowest of 10 other Acute Stroke trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Acute Stroke trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00623389 · 10 participants · NA

    Evaluation of an Advanced Lower Extremity Neuroprostheses

  • NCT01241864 · 10 participants · Phase 2

    Islet Transplantation in Type 1 Diabetic Kidney Allograft

  • NCT01293214 · 10 participants · NA

    Vascularized Composite Allotransplantation for Multiple Extremity Amputations

  • NCT01474148 · 10 participants · NA

    A Neuroprosthesis for Seated Posture and Balance

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03481205, the US trial registry maintained by the National Library of Medicine. NCT03481205 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.